Sanofi position in MGTX
MeiraGTx Holdings plc · Health Care
Sanofi reported holding 12,197,737 shares of MGTX (MeiraGTx Holdings plc) in its Q3 2026 13F filing — a position valued at US$134.2M, representing 21.30% of its reported portfolio and ranking #1 among its reported holdings. Sanofi has disclosed MGTX holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
Last updated: 2026-11-05 · Source: SEC EDGAR Form 13F-HR
How Sanofi's MGTX position evolved
Sanofi first disclosed a stake in MGTX in Q4 2024 at 12,197,737 shares (US$74.3M). The position peaked in Q2 2026 at 12,197,737 shares, worth US$164.8M. Across 8 filings, Sanofi held the position steady without any share-count change. The most recent filing (Q3 2026) shows 12,197,737 shares valued at US$134.2M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 12.20M | $74.28M | New |
| Q1 2025 | 12.20M | $82.70M | Hold |
| Q2 2025 | 12.20M | $79.53M | Hold |
| Q3 2025 | 12.20M | $100.39M | Hold |
| Q4 2025 | 12.20M | $96.97M | Hold |
| Q1 2026 | 12.20M | $105.63M | Hold |
| Q2 2026 | 12.20M | $164.79M | Hold |
| Q3 2026 | 12.20M | $134.18M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About MGTX and 13F data
MGTX (MeiraGTx Holdings plc) is a Health Care company. 52 other funds we track also report a position in MGTX — the largest reported positions include PERCEPTIVE ADVISORS LLC (US$145.7M), Rubric Capital Management LP (US$122.9M), JOHNSON & JOHNSON (US$89.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding MGTX
- PERCEPTIVE ADVISORS LLC 10.79M sh · $145.73M · Q2 2026
- Rubric Capital Management LP 9.10M sh · $122.94M · Q2 2026
- JOHNSON & JOHNSON 6.64M sh · $89.72M · Q2 2026
- Opaleye Management Inc. 3.55M sh · $47.96M · Q2 2026
- 683 Capital Management, LLC 2.30M sh · $31.07M · Q2 2026
- Knoll Capital Management, LLC 1.25M sh · $16.89M · Q2 2026
- Long Focus Capital Management, LLC 1.08M sh · $14.59M · Q2 2026
- HEIGHTS CAPITAL MANAGEMENT, INC 850.00K sh · $11.48M · Q2 2026
- Privium Fund Management B.V. 196.11K sh · $2.65M · Q2 2026
FAQ
How long has Sanofi held MGTX?
Sanofi has disclosed MGTX holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
What is Sanofi's current position in MGTX?
As of Q3 2026, Sanofi holds 12.20M shares of MGTX (MeiraGTx Holdings plc), valued at $134.18M, representing 21.30% of its reported portfolio and ranking #1.
Has Sanofi been buying or selling MGTX?
In the latest 13F filing (Q3 2026), Sanofi held unchanged its position in MGTX. The position peaked in Q2 2026 at 12.20M shares.
Which other funds hold MGTX?
Other major institutional holders of MGTX include PERCEPTIVE ADVISORS LLC, Rubric Capital Management LP, JOHNSON & JOHNSON, among 52 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.